Cargando…
Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein
The etiological agent of severe acute respiratory syndrome (SARS) has been identified as a novel coronavirus SARS-CoV. Similar to other coronaviruses, spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cell...
Autores principales: | Han, Dong P, Kim, Hyung G, Kim, Young B, Poon, Leo L.M, Cho, Michael W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127165/ https://www.ncbi.nlm.nih.gov/pubmed/15262502 http://dx.doi.org/10.1016/j.virol.2004.05.017 |
Ejemplares similares
-
The SARS-CoV S glycoprotein: expression and functional characterization
por: Xiao, Xiaodong, et al.
Publicado: (2003) -
The SARS-CoV S glycoprotein
por: Xiao, X., et al.
Publicado: (2004) -
Real-time allelic assays of SARS-CoV-2 variants to enhance sewage surveillance
por: Xu, Xiaoqing, et al.
Publicado: (2022) -
Comparison of Four SARS-CoV-2 Neutralization Assays
por: Riepler, Lydia, et al.
Publicado: (2020) -
Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization
por: Ding, Shilei, et al.
Publicado: (2020)